AEON Biopharma, Inc. Net Asset Momentum
AEON Biopharma, Inc. net asset momentum. AEON Biopharma, Inc. (AEON) recorded a net asset momentum of 81.3% as of December 2024, with net assets of $-28.57 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore AEON Biopharma, Inc. (AEON) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of AEON Biopharma, Inc. (2019–2024)
Net asset momentum of AEON Biopharma, Inc. from 2019 to 2024. This chart tracks AEON Biopharma, Inc.'s year-over-year net asset growth across 6 annual reporting periods from 2019 to 2024. The most recent momentum reading is +81.3%, with net assets of $-28.57 Million USD as of December 2024. See AEON total equity for net asset value and shareholders' equity analysis.
AEON Biopharma, Inc. Net Asset Momentum by Year (2019–2024)
AEON Biopharma, Inc. net asset momentum by year from 2019 to 2024. The table below shows the complete annual net asset history for AEON Biopharma, Inc. from 2019 to 2024, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see AEON company net worth.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | $-28.57 Million | $3.14 Million | $31.71 Million | ▲ +81.3% |
| 2023 | $-153.04 Million | $6.84 Million | $159.89 Million | ▲ +43.4% |
| 2022 | $-270.41 Million | $10.78 Million | $281.19 Million | ▼ -20.8% |
| 2021 | $-223.82 Million | $6.44 Million | $230.26 Million | ▼ -10.1% |
| 2020 | $-203.23 Million | $21.21 Million | $224.45 Million | ▼ -208.5% |
| 2019 | $-65.87 Million | $114.35 Million | $180.22 Million | — |